Ganglioside GD4, Human (Mitumomab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-Ganglioside GD4, Human (Mitumomab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityGanglioside GD4, Human (Mitumomab biosimilar)
CloneMitumomab
Host SpeciesRecombinant Mouse
Reactive Specieshuman
IsotypeIgG2b kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsELISA, FCM, IP, FuncS, IF, Neut, ICC
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human Ganglioside GD4 Recombinant Antibody (Mitumomab). Mitumomab (BEC-2) is a mouse anti-BEC-2 monoclonal antibody investigated for the treatment of small cell lung carcinoma in combination with BCG vaccination. Mitumomab attacks tumour cells, while the vaccine is thought to activate the immune system. It was developed by ImClone and Merck.
Immunogenn/a
Other NamesAnti-Ganglioside GD4 Recombinant Antibody, Research Grade Mitumomab, Anti-Human Ganglioside GD4 Recombinant Antibody(Mitumomab), BEC2, Antibody Drug Analogues, Monoclonal Antibody, YR1070, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 216503-58-1
Catalog #YR1070
Priceplease inquire
Order / More InfoGanglioside GD4, Human (Mitumomab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.